Smooth Transition with Biotech Managed IT Service

At Capital Techies, we believe that a well-completed job is not just about delivering IT solutions; it’s about enabling our BioTech Managed IT Service clients to thrive and grow. One such success story is our recent collaboration with Vaccitech North America, a leading immunotherapy company spun out of Oxford University. Vaccitech focuses on developing immunotherapeutic products and vaccines to combat infectious diseases and cancer. In 2021, following its acquisition of Avidia Technologies in Maryland, Vaccitech embarked on an exciting journey of expansion.

Capital Techies Ensures Smooth Transition for Vaccitech North America's Expansion

The Challenge: A Growing Need for Space and Infrastructure

With six clinical candidates ready to advance to trials and the acquisition of Avidia Technologies, Vaccitech urgently required a larger facility to serve as its new office headquarters and research and development (R&D) center. The challenge was to make this transition seamless while ensuring that the IT infrastructure could support the company’s evolving needs by cabling and wiring the new space.

The Solution: Capital Techies Steps In

Vaccitech turned to Capital Techies to help build a robust IT foundation and infrastructure for their expanded operations. Our team worked closely with Vaccitech to strategize and implement a comprehensive plan to support the company’s growth seamlessly.

One of the key achievements of this project was the successful transition to a spacious 16,000-square-foot facility located in Germantown, MD. This new facility serves as Vaccitech’s office headquarters and houses a state-of-the-art wet lab, vital for their groundbreaking research.

Capital Techies Ensures Smooth Transition for Vaccitech North America Expansion2

Taking Biotech Managed IT Service to the Next Level

To meet Vaccitech’s unique needs, we installed 12 cutting-edge conference rooms with state-of-the-art technology. These rooms feature Logitech Rally and Logitech Teams equipment, ensuring that every meeting and collaboration session runs smoothly.

In addition to the advanced conference rooms, we deployed 20 access points strategically throughout the facility. This move guarantees reliable network connectivity and supports seamless organizational communication and data transfer.

Furthermore, we implemented over 300 data drops, providing the infrastructure needed for Vaccitech’s extensive research and data management requirements. This network expansion was pivotal in accommodating the increased data transmission and storage demand.

Capital Techies Ensures Smooth Transition for Vaccitech North America Expansion3

A Remarkable Transformation

The collaboration between Capital Techies and Vaccitech North America resulted in a remarkable transformation in their Biotech Managed IT Service. Our team’s expertise ensured that the company’s move to a larger and more advanced facility was executed seamlessly. The new headquarters and R&D center are now equipped to support Vaccitech’s innovative work in the field of immunotherapy.

At Capital Techies, we take pride in contributing to the success of organizations like Vaccitech, helping them expand their capabilities and achieve their goals. As we celebrate this achievement, we look forward to continuing our partnership with Vaccitech and other forward-thinking companies on their journeys toward excellence while maintaining HIPPA compliance.

Contact Capital Techies for Your IT Needs

If you’re planning an expansion or need to upgrade your IT infrastructure, contact Capital Techies today. Our experienced team is here to provide tailored solutions to meet your unique and cybersecurity requirements, just as we did for Vaccitech North America. Together, we can ensure your IT infrastructure supports your growth and success.